Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V419 (hexavalent vaccine) in healthy infants
NCT01341639Phase 3Completed
- Sponsor
- MCM Vaccine
- Start
- May 2011
- Primary completion
- Mar 2013
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of haemophilus influenzae type b vaccine in diphtheria, Tetanus, pertussis, poliomyelitis, Haemophilus influenzae type b infection (Hib), sponsored by MCM Vaccine. Started May 2011; status: completed.
02
Drugs
haemophilus influenzae type b vaccine
03
Conditions
diphtheriaTetanuspertussispoliomyelitisHaemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT01341639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01341639.